Trial Profile
An Open-label, Single and Repeat Single Ascending Dose Escalation Study to Compare the Pharmacokinetics of Metformin Eicosapentaenoate With Metformin Hydrochloride and Icosapent Ethyl Following Oral Administration to Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Eicosapentaenoic acid/metformin (Primary) ; Ethyl eicosapentaenoic acid; Metformin
- Indications Hypertriglyceridaemia; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Thetis Pharmaceuticals
- 25 Apr 2022 Status changed from recruiting to completed.
- 27 May 2014 New trial record